Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy
NCT07313384 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2026-02-19
Summary
The DINE-GLP1 study aims to understand how people on GLP-1 therapy change their eating habits and what kind of dietary support they need. As more people use GLP-1 medications, there's not much guidance on what they should eat, mostly just focusing on managing symptoms and cutting calories. Since these medications reduce food intake, it's important to ensure the diet is nutritious even with fewer calories to help with long-term weight control and health. Most research has looked at how the body responds to the medication and whether patients take it as prescribed, but not much is known about what patients actually experience, what they think they need, or how they could use additional support. Understanding patients' views can help create better lasting solutions. Note that this study does not provide free GLP-1 medication.
Conditions
- Obesity Type 2 Diabetes Mellitus
- Obesity (Disorder)
Interventions
- DRUG
-
GLP-1 Therapy
Exposure to GLP-1 Therapy for obesity or T2DM management.
Sponsors & Collaborators
-
Prisma Health-Upstate
collaborator OTHER -
University of South Carolina
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-02-11
- Primary Completion
- 2026-11-01
- Completion
- 2026-12-01
Countries
- United States
Study Locations
More Related Trials
-
Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness
NCT06487832 ·Status: RECRUITING ·Phase: NA
-
Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists
NCT06818292 ·Status: COMPLETED ·Phase: NA
-
Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
NCT05067621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Blood Pressure Outcomes With Liraglutide Therapy
NCT01755572 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes
NCT01363609 ·Status: COMPLETED ·Phase: NA
-
A Study of Oral GLP1RA RGT001-075 in Adults With Type 2 Diabetes
NCT05297045 ·Status: TERMINATED ·Phase: PHASE2
-
The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients
NCT06243536 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effect of a Glucagon Like Peptide 1 (GLP1) Booster in Healthy Humans
NCT06333496 ·Status: COMPLETED ·Phase: NA
-
Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET
NCT01185119 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
NCT01234649 ·Status: COMPLETED ·Phase: PHASE3
-
GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
NCT06338553 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
To Determine the Effect of GLP1 on Cognitive Function, Brain Glucose Metabolism and Neuroplasticity.
NCT03414333 ·Status: COMPLETED ·Phase: NA
-
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)
NCT04261933 ·Status: COMPLETED
-
The Effect of Semaglutide on Pituitary Function
NCT04865744 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients
NCT06924697 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients with Type 2 Diabetes
NCT05078255 ·Status: COMPLETED ·Phase: NA
-
Glucagon Like Peptide 1 (GLP-1) Booster™ RCT Study
NCT07141472 ·Status: COMPLETED ·Phase: NA
-
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
NCT02584582 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Effect of GLP-1 on the Inhibition of Glucagon Secretion
NCT01507597 ·Status: COMPLETED ·Phase: NA
-
GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations
NCT02082496 ·Status: COMPLETED ·Phase: PHASE2
-
Eating Disturbances in Patients With Type 1 Diabetes Initiating Insulin Therapy
NCT07151924 ·Status: ACTIVE_NOT_RECRUITING
-
Glucagon-like Peptide 2 - a Glucose Dependent Glucagonotropic Hormone?
NCT03954873 ·Status: COMPLETED ·Phase: NA
-
GLP-1 Receptor Agonist Use and Incidence of Retained Gastric Food on Endoscopy
NCT05875636 ·Status: COMPLETED
-
Effects of Oral GLP-1 on Glucose Homeostasis and Appetite Profile in Healthy Male Subjects
NCT00822003 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Near Normalisation of BG Improves the Potentiating Effect of GLP-1
NCT00612625 ·Status: COMPLETED ·Phase: NA